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Introduction
Amiodarone is a class III anti-
arrhythmic drug commonly used for 
treatment and prevention of cardiac 
arrhythmias. It is associated with a number 
of side effects including thyroid dysfunction 
due to its high iodine content and direct 
toxic effects.    
In the United States, 3 to 5 percent of 
patients treated with amiodarone develop 
hyperthyroidism.
1
 Amiodarone-induced thy-
rotoxicosis (AIT) is divided into 2 types. 
Type 1 is associated with increased 
synthesis of thyroid hormone, whereas type 
2 is associated with excessive release of 
thyroxine (T4) and triiodothyronine (T3) 
from a destructive process. The diagnosis of 
thyroid storm is based upon clinical findings 
which are exaggerations of typical hyper-
thyroidism involving the central nervous, 
gastrointestinal, and cardiovascular systems.   
The most accepted criteria to diagnose 
thyroid storm was created by Burch and 
Wartofsky who introduced a scoring system 
in 1993.
2
 It provided a criterion to grade 
severity of thermoregulatory, cardio-
vascular, and central nervous system 
dysfunctions with scores greater than 45 
being highly suggestive of thyroid storm. 
Medical therapy for thyroid storm is 
centered on thionamides, glucocorticoids, 
and beta-blockers. Plasma exchange and 
thyroidectomy have been used in patients 
whose hyperthyroidism is refractory to 
aggressive medical therapy. In our case, 
thyroid artery ablation also was utilized 
when too ill to undergo surgical 
thyroidectomy. 
 
Case Report 
A 64-year-old Caucasian male with a 
history of ischemic cardiomyopathy and 
recurrent ventricular arrhythmia was 
maintained on amiodarone therapy. He had 
no known prior thyroid disease. He was 
admitted to an outside facility after 
experiencing three separate automatic 
implantable cardioverter defibrillator 
(AICD) events. An AICD interrogation 
showed recurrent episodes of ventricular 
fibrillation. Left heart catheterization, with 
associated iodinated contrast exposure, 
revealed no ischemic disease.  
On transfer to our facility, the patient 
had a temperature of 38.0 degrees Celsius, 
respiratory rate of 28 breaths per minute, 
heart rate of 99 beats per minute, and blood 
pressure of 100/58 mmHg. His examination 
showed an anxious, mildly diaphoretic male 
with irregular tachycardia, a fine tremor, 
trace lower extremity edema, and no 
thyromegaly or nodularity. His Burch and 
Wartofsky score was 40, suggestive of 
impending thyroid storm. The thyroid 
stimulating hormone (TSH) level was 0.01 
mIU/mL, with a free thyroxine (FT4) level 
greater than 6.0 ng/mL, and a free 
triiodothyronine (FT3) level of 13.3 ng/dL.   
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Thyroid autoantibodies were not 
detected. He was started on prednisone, 
methimazole (MMI) 20 mg by mouth three 
times daily, and an intravenous (IV) esmolol 
drip.  
The patient continued to have frequent 
episodes of ventricular fibrillations and 
AICD shocks. Given his clinical instability 
and lack of sufficient response to medical 
therapy, we pursued additional possible 
treatments. He received three, 1:1 total 
exchanges on three separate days with 
improved thyroid function studies (TFTs), 
but his mental status and hemodynamics 
worsened, culminating in cardiac arrest 
requiring five minutes of cardiopulmonary 
resuscitation. In lieu of conventional 
surgical thyroidectomy given his unstable 
clinical status, urgent bilateral thyroid artery 
ablation was performed in interventional 
radiology on hospital day 5. Plasmapheresis 
was resumed the next day along with 
medical therapy. The patient underwent nine 
total plasma exchanges with improvement of 
TFTs (Figure 1), resolution of arrhythmias, 
and improvement in his clinical status. He 
eventually underwent thyroidectomy on 
post-hospital day 17 with pathology 
showing a benign multinodular thyroid 
gland. He was started on weight-based 
levothyroxine replacement after his TFTs 
normalized.
 
Figure 1.  Variations in total T3 and free T4 over the course of treatment. 
Discussion 
Amiodarone induced thyrotoxicosis has 
occurred in 3% of patients treated with 
amiodarone.
3
 In hospitalized patients, the 
incidence of thyroid storm was 0.20 per 
100,000 patients per year.
4
 In patients with 
underlying thyroid abnormalities, type I AIT 
occurred due to iodine-induced excessive 
thyroid hormone synthesis. Its pathogenesis 
could be related to effects of iodine overload 
on an abnormal thyroid gland, such as latent 
Graves’ disease, autonomous nodules, or 
multinodular goiter.
5
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Beta blockers, thionamides, and gluco-
corticoids are typically the first line 
treatment for thyroid storm.
6
 Beta blockers 
work by inhibiting 5’-monodeiodinase, thus 
inhibiting conversion of T4 to T3.  
Propanolol is a nonselective beta blocker 
and can be given emergently and 
intravenously as well as in oral form for 
long term use. Esmolol competitively blocks 
response to beta 1 adrenergic stimulation 
and beta 2 receptors at high doses, but is 
limited to IV use. 
Thionamides include propylthiouracil 
(PTU) and methimazole and work slowly by 
blocking de novo thyroid hormone synthesis 
without affecting levels of preformed 
thyroid hormones.
6
 PTU also has additional 
effects of blocking T4 to T3 conversion.  
Glucocorticoids reduce conversion of T4 to 
T3. 
Given our patient’s recent iodinated 
contrast exposure, he was not a candidate for 
radioactive iodine ablation. In addition to 
conventional therapy with MMI, esmolol, 
and prednisone, lithium and cholestyramine 
were discussed, but not utilized, because of 
their side effects and lack of efficacy.  
Plasmapheresis was initiated in lieu of 
thyroidectomy given his unstable clinical 
status. 
The purpose of plasmapheresis is to 
remove plasma containing preformed 
thyroid hormones from circulation and 
replace it with plasma containing normal 
levels of thyroid hormones. Removal of 
circulating autoantibodies against the 
thyroid gland also could contribute to 
improvement in patient’s TFTs and 
subsequent clinical status.
7
 However, there 
have been no clinical trials evaluating 
plasmapheresis as a treatment modality in 
thyrotoxicosis. 
In published reports using 
plasmapheresis for treatment of 
thyrotoxicosis,
7-11
 some used two exchanges 
while others used up to eight exchanges. No 
reports studied the optimal number of 
plasma exchanges and most discontinued 
plasmapheresis after clinical improvement 
rather than improvement in TFTs. Most 
demonstrated benefit from plasma-
pheresis.
7-10
 Of note, the use of plasma-
pheresis often improved the patients’ 
clinical status until they could undergo 
thyroidectomy.
7,8,10
 The use of plasma-
pheresis in treatment of other conditions is 
associated with thyroid hormone 
disorders.
13,14
 
Pasimeni et al.
8 
reported a 57-year-old 
female with a known multinodular goiter 
who developed thyrotoxicosis induced by an 
iodinated contrast agent received for a 
computed tomography scan, a mechanism 
similar to type 1 AIT. She ultimately was 
treated with two sessions of therapeutic 
plasma exchange. Her FT3 and FT4 levels 
and clinical symptoms improved to enable a 
thyroidectomy without complications.  
Indications for thyroid artery 
embolization in AIT are not well elucidated.  
Few cases described thyroid artery 
embolization for treatment of thyroid 
disease. Xiao et al.
14 
described the utilization 
of thyroid artery embolization in 22 patients 
with Graves’ disease in patients unable to 
tolerate or not accepting of current therapies 
(oral medication, radioactive iodine, or 
surgery). Six received embolization 
followed by thyroidectomy with the 
remaining 16 receiving embolization only.  
Fourteen remained euthyroid. Only two 
patients required maintenance doses of anti-
thyroid drugs. No adverse effects were 
described from the thyroid artery 
embolization. 
Zhao et al.
15
 used thyroid arterial 
embolization in 37 patients with Graves’ 
disease to study pathological changes of the 
thyroid gland. They discovered ischemia, 
then necrosis, of the gland at seven days 
post-embolization. Of the 37 patients, 26 
were rendered euthyroid at follow-up in 
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three years and all improved TFTs in seven 
days along with some improvement in 
clinical status. 
In our case, the patient was clinically 
unstable despite three plasma exchanges and 
he continued to have elevated TFTs. His 
TFTs briefly increased after ablation which 
was attributed to destruction and necrosis of 
his thyroid gland and release of preformed 
thyroid hormones. After two additional 
plasma exchanges, his clinical status and 
TFTs improved, allowing the patient to 
undergo thyroidectomy. Our case illustrated 
the potential severity of AIT and the 
successful use of plasmapheresis and thyroid 
artery embolization in its treatment. 
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